Stilla Technologies

Acquired

Digital PCR

Villejuif, France · Founded 2013 · $66.5M raised

Headquarters
Villejuif
Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$66.5M
Last Round
$26.5M Series CFeb 2024
Rounds
5
Acquired by
Bio-Rad LaboratoriesFeb 2025 · $225.0M

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 10 investors for this company. The full record is or through the API.

About

Stilla Technologies was a Paris-based biotechnology company founded in 2013 by Rémi Dangla and Clément Gay, specializing in multiplex digital PCR technology for life sciences research and clinical diagnostics. The company developed the naica Crystal Digital PCR system and the Nio product line, offering unique 7-color target detection capability that enabled high-resolution genetic analysis. Stilla's digital PCR platform served researchers and clinicians across oncology, infectious disease, genetic testing, and liquid biopsy applications. The company raised a €26.5 million Series C in 2024. Stilla was acquired by Bio-Rad Laboratories for up to $275 million in a deal announced in February 2025.

Summary

Stilla Technologies is a Biotech company based in Villejuif, France, founded in 2013. It has raised $66.5M in total across 5 rounds, most recently a $26.5M Series C round in Feb 2024. Investors include Illumina Ventures, Kurma Partners and Partech.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionFeb 2025

Sign up to see all 7 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Stilla Technologies on Indexed.vc
<a href="https://indexed.vc/companies/stilla-technologies"><img src="https://indexed.vc/api/badge/company/stilla-technologies" alt="Stilla Technologies on Indexed.vc" width="260" height="76" /></a>